Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Overview of Cell-Matrix Interactions

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...

Matrix Proteoglycans and Glycoproteins

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Peptide nanofibers and PAMP agonist combinations enhance pulmonary CD4 + T cell functionality of immune recall to vaccination.

Journal of nanobiotechnology·2026

Same author

Stereoselective Coassembly of Chiral Isomer Peptide Pairs.

ACS materials Au·2026

Same author

Peptide nanofibers and PAMP agonist combinations enhance pulmonary CD4<sup>+</sup>T cell functionality of immune recall to vaccination.

Journal of nanobiotechnology·2026

Same author

Substituent-Based Modulation of Self-Assembly and Immunogenicity of Amphipathic Peptides.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Mapping fusion-driven cell reprogramming through integrative single-cell computational frameworks.

NPJ systems biology and applications·2025

Same author

Immunomodulatory biomaterials for treating chronic inflammation at mucosal sites.

npj biomedical innovations·2025

Same journal

Corrigendum to "Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib" [Biomaterials 2020, 240, 119845].

Biomaterials·2026

Same journal

Mg-integrated octopus-inspired hydrogel dressing enables autonomous adhesion and wound closure for enhanced healing via sequential microenvironment regulation.

Biomaterials·2026

Same journal

Engineering miRNA-223 nanocomplexes via bioorthogonal self-assembly for precision therapy of intervertebral disc degeneration.

Biomaterials·2026

Same journal

Corrigendum to "Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide" [Biomaterials 42 (2015) 16442].

Biomaterials·2026

Same journal

An injectable Ce-MnCo LDH nanozyme gel with cascade catalytic activity for acute radiation proctitis in rats.

Biomaterials·2026

Same journal

Peptide coacervate-mediated siRNA delivery for dual PD-1/PD-L1 blockade to enhance colorectal cancer immunotherapy.

Biomaterials·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Published on: May 3, 2024

Co-assembling peptides as defined matrices for endothelial cells.

Jangwook P Jung¹, Arun K Nagaraj, Emily K Fox

¹Department of Surgery, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.

|February 11, 2009

Summary

This summary is machine-generated.

Researchers developed peptide hydrogels for regenerative medicine. These biomaterials effectively support cell growth and attachment without altering material properties or causing significant immune responses, making them promising for in vitro and in vivo applications.

More Related Videos

Culturing Mammalian Cells in Three-dimensional Peptide Scaffolds

Culturing Mammalian Cells in Three-dimensional Peptide Scaffolds

Published on: June 13, 2018

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Published on: December 26, 2019

Related Experiment Videos

Last Updated: Jun 25, 2026

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Published on: May 3, 2024

Culturing Mammalian Cells in Three-dimensional Peptide Scaffolds

Culturing Mammalian Cells in Three-dimensional Peptide Scaffolds

Published on: June 13, 2018

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Published on: December 26, 2019

Area of Science:

Biomaterials Science
Regenerative Medicine
Peptide Self-Assembly

Background:

Self-assembling peptides are explored as cell culture matrices and regenerative medicine scaffolds.
Ligand display on scaffolds should not alter physicochemical properties like viscoelasticity.
Biomaterials for in vivo use require low immunogenicity.

Purpose of the Study:

To design multi-peptide co-assembling hydrogels presenting cell-binding ligands (RGDS or IKVAV) on fibril surfaces.
To assess if ligand incorporation alters scaffold properties or cell behavior.
To evaluate the immunogenicity of the developed hydrogels.

Main Methods:

Co-assembly of Q11 peptide with RGDS-Q11 or IKVAV-Q11 peptides.
Characterization of hydrogel fibrillization, secondary structure, and stiffness.
Assessment of human umbilical vein endothelial cell (HUVEC) attachment, spreading, morphology, and growth.
Evaluation of immunogenicity in mouse models.

Main Results:

Ligand incorporation did not significantly alter hydrogel fibrillization, secondary structure, or stiffness.
RGDS-Q11 co-assembled gels enhanced HUVEC attachment, spreading, and growth.
IKVAV-Q11 co-assembled gels showed subtle effects on HUVEC attachment and morphology.
Q11 and RGDS-Q11 exhibited minimal immunogenicity in mice.

Conclusions:

Q11-based peptide hydrogels can present cell-binding ligands without compromising material integrity.
These hydrogels modulate HUVEC behavior, with RGDS-Q11 showing significant effects.
The low immunogenicity of Q11 and RGDS-Q11 makes them suitable for further investigation as defined extracellular matrices for in vitro and in vivo applications.